Deepa Kumari | Nanotechnology | Women Researcher Award

Posted on by sciencefather

Dr. Deepa Kumari | Nanotechnology | Women Researcher Award

Regional Institute of Education, Bhubaneswar India

👨‍🎓Profiles

🎓 Academic Qualifications

Dr. Deepa Kumari, based at the Regional Institute of Education, Bhubaneswar, India, holds an impressive academic background with an M.Sc., M.Phil., and Ph.D. in Chemistry. She has also successfully qualified the KSET (Karnataka State Eligibility Test), reflecting her scholarly competence and readiness for higher education teaching and research.

👩‍🏫 Teaching Experience

Dr. Deepa Kumari has accumulated over 10 years of teaching experience at the postgraduate level, mentoring M.Sc. Chemistry and M.Sc. Organic Chemistry students, alongside B.Sc., B.Ed. aspirants. Between 2021 and 2023, she also contributed significantly to Ph.D. and M.Phil. programs by delivering specialized lectures for Ph.D. coursework students at the Department of Studies in Chemistry, University of Mysore, Mysuru. Her ability to engage with students across undergraduate, postgraduate, and doctoral levels highlights her versatility and deep commitment to academic excellence.

🔬 Research Contributions and Guidance

Recognized as an official Research Guide by the University of Mysore in 2021, Dr. Deepa is actively supervising three Ph.D. scholars who are currently pursuing their research under her guidance. Her mentorship focuses on fostering critical thinking, experimental rigor, and original contribution to the field of chemical sciences, particularly in organic and electrochemical domains.

🧪 Research Projects and Collaborations

Dr. Deepa has successfully completed a UGC-sponsored Minor Research Project (MRP) in 2019, titled “Synthesis and characterization of novel Hydantoin derivatives for their Electrochemical applications.” This project emphasized creating new compounds with potential electrochemical functionalities, showcasing her expertise at the intersection of synthetic organic chemistry and applied electrochemistry. Additionally, she played a crucial role as a Co-coordinator for the ‘Prakriti Mela’ project in 2025, sponsored by NCERT, aiming to promote environmental awareness and scientific curiosity among school students in Bhubaneswar. This endeavor reflects her commitment to extending the impact of science beyond academia to the broader community.

📚 Academic Influence and Impact

Through a decade of dedicated teaching, notable research projects, and active Ph.D. supervision, Dr. Deepa Kumari has established herself as a respected educator and researcher. Her work not only enriches the academic environment at the Regional Institute of Education but also contributes meaningfully to the wider fields of organic chemistry and electrochemical studies.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Deepa Kumari is poised to continue nurturing future generations of chemists and expanding her research portfolio. Her efforts in advancing synthetic methodologies, promoting environmental education, and integrating research with teaching underscore her lasting commitment to the advancement of science and education in India.

📖Notable Publications

  • CuO nanoparticles: green combustion synthesis, applications to antioxidant, photocatalytic and sensor studies
    Journal: RSC Advances
    Year: 2024
    Authors: Raju Prakruthi, Hemavathi Nagaraju Deepakumari

  • LC-MS/MS characterization of pirtobrutinib impurities and product degradation: stability studies
    Journal: RSC Advances
    Year: 2024
    Authors: Modachakanahally K. Pavithra, Chaya G., Hemavathi N. Deepakumari, Hosakere D. Revanasiddappa, Salah Jasim Mohammed, Hasan Sh. Majdi, Abdullah H. Alsabhan, Shareefraza J. Ukkund

  • Multifunctional applications of bismuth vanadate nanoparticles: enhanced photocatalytic, good sensor and supercapacitor property
    Journal: Journal of Materials Science: Materials in Electronics
    Year: 2024
    Authors: R. Prakruthi, H. N. Deepakumari, C. Mallikarjunaswamy, H. D. Revanasiddappa, G. Nagaraju

  • Silver vanadate nanoparticles: Green synthesis, enhanced photocatalytic and antibacterial activity
    Journal: AIP Advances
    Year: 2024
    Authors: R. Prakruthi, H. N. Deepakumari, H. D. Revanasiddappa, Faisal M. Alfaisal, Shamshad Alam, Hasan Sh. Majdi, Mohammad Amir Khan, Shareefraza J. Ukkund

Sourav De | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Sourav De | Medicinal Chemistry | Best Researcher Award

Eminent College of Pharmaceutical Technology, India

👨‍🎓Profiles

🎓 Education and Academic Background

Dr. Sourav De is a distinguished researcher and educator currently affiliated with Eminent College of Pharmaceutical Technology, India. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from the School of Advanced Sciences, Vellore Institute of Technology (VIT), India (March 2017 – December 2020). Under the guidance of Dr. S. K. Ashok Kumar, Professor, his doctoral thesis focused on the design, synthesis, characterization, and anticancer evaluation of various heterocycles and Ru(II)-arene-N^N, N^O, N^S complexes. His strong academic foundation also includes an M.Pharm in Pharmaceutical Chemistry from West Bengal University of Technology (2010–2012), where he graduated with a CGPA of 8.79 (First Class), and a B.Pharm from the University of North Bengal (2006–2010), securing 74% (First Class).

🔬 Research Interests

Dr. Sourav De’s research interests span a diverse range of medicinal chemistry and organometallic chemistry, with a strong emphasis on the therapeutic applications of organic and organometallic complexes. His key areas of focus include: Molecular Modeling and In-Silico Studies for drug discovery and computational chemistry. Chromogenic and Fluorogenic Sensors for biomedical and pharmaceutical applications. Cancer Research, particularly in the treatment of cervical, colon, breast, and brain tumors.

🏆 Research Projects

Dr. De has actively contributed to multiple academic research and technology development projects, showcasing his expertise in cancer theranostics, drug discovery, and molecular design. Notable projects include: DST-SERB Sponsored Project: He worked as a Project Assistant on the Development of novel 2-aryl benzothiazole/benzoxazole, quinoxaline, and phenanthroline analogues as fluorescent probes and cancer theranostics applications (EMR/2017/000816). Grant-in-Aid SEED Fund Research Project: As a Principal Investigator, he led a research project titled “In silico analysis of some ruthenium complexes as potential anti-cancer agents,” funded by Rs. 85,000 (AU/REG/NOT/2021/04/003). With over 11 years and 9 months of research experience, Dr. De has made impactful contributions to the fields of drug development and computational chemistry.

🛠️ Technical Skills

Dr. Sourav De possesses strong technical expertise across various analytical instruments, imaging techniques, and computational tools. His skill set includes: Instruments Handled: UV, FL, FTIR, CD spectroscopy, ELISA reader, Gel Doc, and HPLC. Imaging Techniques: Fluorescent Microscopy, Scanning Electron Microscopy (SEM), and Flow Cytometry. Computational and Analytical Tools: Molecular Modeling & Docking: AutoDock 4.2, AutoDock Vina, Chimera 1.11rc, Open Babel GUI. Data Analysis: Python for scientific computing and data visualization. Plotting and Molecular Visualization: Origin, ChemDraw, ChemSketch. Hands-on Experience: Cell culture, molecular biology, and bioinformatics for drug-target interactions and cancer research.

📚 Teaching Experience

Dr. De is an experienced educator specializing in pharmaceutical and medicinal chemistry. He has taught various subjects, including: Pharmaceutical Chemistry & Medicinal Chemistry, Organic and Inorganic Chemistry, Pharmaceutical Analysis & Instrumental Analysis. His teaching methodology combines practical applications and research-driven insights, ensuring students gain both theoretical knowledge and hands-on experience.

🌟 Future Research and Contributions

Dr. Sourav De is committed to advancing therapeutic drug design, molecular diagnostics, and cancer research. His future work aims to develop targeted anticancer drugs, bioactive organometallic complexes, and AI-driven molecular modeling techniques. With his expertise in pharmaceutical sciences and computational chemistry, he continues to make significant contributions to drug discovery and medicinal research.

📖Notable Publications

  • Pyridine: the scaffolds with significant clinical diversity

    • Authors: S De, AK SK, SK Shah, S Kazi, N Sarkar, S Banerjee, S Dey
    • Journal: RSC Advances
    • Year: 2022

  • Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer

    • Authors: S De, S Banerjee, SKA Kumar, P Paira
    • Journal: Mini Reviews in Medicinal Chemistry
    • Year: 2019

  • Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium (II)–arene-2-heteroarylbenzoxazole complexes

    • Authors: S De, SR Chaudhuri, A Panda, GR Jadhav, RS Kumar, P Manohar, …
    • Journal: New Journal of Chemistry
    • Year: 2019

  • Amberlite IR-120 (H) mediated “on water” synthesis of fluorescent Ruthenium (II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging

    • Authors: A Mondal, S De, S Maiti, B Sarkar, AK Sk, R Jacob, A Moorthy, P Paira
    • Journal: Journal of Photochemistry and Photobiology B: Biology
    • Year: 2018

  • Luminescent ruthenium (II)-para-cymene complexes of aryl substituted imidazo-1,10-phenanthroline as anticancer agents and the effect of remote substituents on cytotoxic activities

    • Authors: S De, RS Kumar, A Gauthaman, SKA Kumar, P Paira, A Moorthy, …
    • Journal: Inorganica Chimica Acta
    • Year: 2021

Ayush Amod | Nanotechnology | Best Researcher Award

Posted on by sciencefather

Mr. Ayush Amod | Nanotechnology | Best Researcher Award

Indian Institute of Information Technology, India

👨‍🎓Profiles

🎓 Early Academic Pursuits

Ayush Amod began his academic journey with a strong foundation in Life Sciences, earning both his Bachelor's and Master's degrees from the University of Allahabad (UoA), India. His keen interest in interdisciplinary sciences led him to pursue a Master of Technology (M.Tech) in Bioinformatics from the Indian Institute of Information Technology, Allahabad (IIIT-A). With a passion for research, he secured a prestigious Junior Research Fellowship (JRF) by ICMR (All India Rank-18) and also qualified the National Eligibility Test (NET) by CSIR (All India Rank-50), showcasing his excellence in the field of medical and computational biology.

🏅 Professional Endeavors

Currently serving as an ICMR-SRF Research Scholar at IIIT-Allahabad, Ayush Amod is in the final phase of his doctoral studies at the Department of Applied Sciences. His research is primarily centered on understanding bacterial biofilm infections, nanobiotechnology, and bioinformatics. His collaborative efforts with Central Drug Research Institute (CDRI), Lucknow have further enhanced the translational impact of his work.

🔬 Contributions and Research Focus

Ayush Amod’s research contributions have been instrumental in advancing bioinformatics and computational biology, particularly in drug discovery and disease therapeutics. His work on strigolactone analogues focused on investigating the role of HDAC1 and HDAC2 inhibitors in hepatocellular carcinoma, leading to a significant publication in Biotechnology Letters (2022). During the COVID-19 pandemic, he contributed to drug discovery by evaluating the phytoconstituents of Tinospora cordifolia against SARS-CoV-2 K417N and N501Y mutant spike glycoprotein and its main protease, providing valuable insights into potential antiviral therapeutics. Additionally, he played a key role in the development of the Anti-Ebola Peptide Database (AEPDB), a specialized and comprehensive resource of antiviral peptides against the Ebola virus, making a meaningful impact on computational virology and peptide-based drug discovery.

📊 Impact and Influence

Ayush has made remarkable progress in the field of bioinformatics, contributing to 7 SCI-indexed research papers and maintaining an h-index of 4 and i10-index of 2, reflecting the significance of his work. His research bridges the gap between computational biology and medical sciences, aiding drug discovery and therapeutic development.

📚 Academic Citations & Publications

With a total of 7 SCI-indexed publications, his work is gaining widespread recognition in the scientific community. His research has been referenced by fellow scholars working in drug discovery, computational biology, and nanobiotechnology.

🛠 Technical Skills

Ayush possesses expertise in a diverse range of computational and laboratory techniques, enabling him to make significant contributions to bioinformatics and drug discovery. His proficiency in molecular docking and dynamics simulations allows for the detailed analysis of biomolecular interactions, crucial for understanding drug-target mechanisms. He is skilled in computational drug discovery, utilizing advanced algorithms and modeling techniques to identify potential therapeutic compounds. Additionally, his experience in bioinformatics database development has contributed to the creation of specialized resources for antiviral research. With a strong background in high-performance computing for biological data analysis, he efficiently processes large-scale genomic and proteomic datasets, enhancing the accuracy and speed of computational biology applications.

🎓 Teaching Experience & Knowledge Sharing

As a dedicated researcher, Ayush has mentored junior scholars in bioinformatics and computational biology. He has actively engaged in scientific discussions and workshops to help budding researchers develop skills in molecular modeling, drug discovery, and bioinformatics tools.

🌟 Legacy and Future Contributions

With an interdisciplinary research approach, Ayush Amod is poised to make groundbreaking contributions in computational biology and nanobiotechnology. His ongoing research on bacterial biofilm infections and drug resistance will play a crucial role in developing novel therapeutic strategies. Looking ahead, he aims to expand his work in AI-driven drug discovery and personalized medicine, contributing towards a better understanding of infectious diseases and their treatment.

📖Notable Publications

  1. A Specialized and Comprehensive Resource of Antiviral Peptides against Ebola Virus
    • Authors: Mondal, R.K., Anand, A.A., Amod, A., Pal, O., Samanta, S.K.
    • Journal: International Journal of Peptide Research and Therapeutics
    • Year: 2025
  2. A comprehensive guide on screening and selection of a suitable AMP against biofilm-forming bacteria
    • Authors: Anurag Anand, A., Amod, A., Anwar, S., Sethi, G., Samanta, S.K.
    • Journal: Critical Reviews in Microbiology
    • Year: 2024
  3. Finding Novel AMPs Secreted from the Human Microbiome as Potent Antibacterial and Antibiofilm Agents and Studying Their Synergistic Activity with Ag NCs
    • Authors: Singh, A., Amod, A., Mulpuru, V., Sahoo, A.K., Samanta, S.K.
    • Journal: ACS Applied Bio Materials
    • Year: 2023
  4. Evaluation of phytoconstituents of Tinospora cordifolia against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study
    • Authors: Choudhary, P., Singh, T., Amod, A., Singh, S.
    • Journal: Journal of Biomolecular Structure and Dynamics
    • Year: 2023
  5. Network pharmacological evaluation of strigolactones efficacy as potential inhibitors against therapeutic targets of hepatocellular carcinoma
    • Authors: Amod, A., Pahal, S., Choudhary, P., Gupta, A., Singh, S.
    • Journal: Biotechnology Letters
    • Year: 2022
  6. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies
    • Authors: Singh, A., Amod, A., Pandey, P., Sahoo, A.K., Samanta, S.K.
    • Journal: Biomedical Materials (Bristol)
    • Year: 2022

Yi Yan Yang | Nanomedicine | Best Researcher Award -1584

Posted on by sciencefather

Prof. Dr. Yi Yan Yang | Nanomedicine | Best Researcher Award

Bioprocessing Technology Institute, Singapore

👨‍🎓Profiles

🎓 Early Academic Pursuits

Yi Yan Yang began her academic journey in chemical engineering at Tsinghua University, P.R. China, where she served as an Assistant/Associate Professor from 1990 to 1998. Her foundation in polymer science and chemical engineering laid the groundwork for a remarkable career in biomedical innovation and nanomedicine. This period marked her transition into interdisciplinary research, focusing on advanced materials and their practical applications.

💼 Professional Endeavors

Her illustrious career spans multiple leadership roles within ASTAR, Singapore. She served as Group Leader at the Institute of Bioengineering and Nanotechnology (IBN), progressing to key executive positions such as Covering Executive Director at both IBN and the Institute of Bioengineering and Bioimaging. Currently, she holds the title of Distinguished Principal Scientist at the Bioprocessing Technology Institute (BTI), ASTAR. Additionally, since 2019, she has been an Adjunct Professor at the Department of Orthopedics, National University of Singapore (NUS). Her leadership and strategic vision have significantly shaped Singapore's research landscape.

📚 Contributions and Research Focus

She has made groundbreaking contributions in the fields of polymer science, nanocarriers, nanomedicine, and drug delivery systems. She has led 56 research projects, collaborating with global industry leaders like IBM, Merck MSD, and Procter & Gamble. Her work includes the development of antimicrobial and antiviral polymer coatings, polymeric hydrogels for antibody delivery, and novel nanocarriers for mRNA vaccine delivery. Her innovations extend to tackling antimicrobial resistance, polymer-based drug delivery systems, and mRNA therapeutics, significantly contributing to infectious disease treatment and next-generation vaccines.

🔭 Impact and Influence

Her research has had a global impact, as evidenced by her h-index of 95 and over 29,000 citations on Google Scholar. Recognized as a Clarivate Highly Cited Researcher in 2022, her contributions include pioneering antimicrobial polymers, which were named among Scientific American’s Top 10 World-Changing Ideas. Her technologies have led to the founding of companies like TriSafe HealthTech Pte. Ltd., translating laboratory research into real-world applications that address critical global health challenges.

🌟 Academic Publications and Patents

She has authored 303 publications in prestigious journals, including Nature Materials, Nature Nanotechnology, ACS Nano, and Advanced Materials. Her portfolio also boasts 92 patents, demonstrating her innovative spirit and commitment to advancing technology. These publications and patents underscore her expertise in drug/gene delivery systems, antimicrobial technologies, and nanomedicine.

💡 Collaborations and Partnerships

Her collaborations with globally renowned researchers, such as Dr. James L. Hedrick (IBM Almaden Research Center) and Dr. Yue Wan (Genome Institute of Singapore), have led to advancements in polymer chemistry, mRNA vaccine development, and therapeutics. Her partnerships extend to prominent institutions and industries, including Smithfield Hog Production, IHI, and ST Dynamics, fostering innovation across biomedical, pharmaceutical, and consumer care sectors.

📈 Legacy and Future Contributions

Her legacy is defined by her transformative work in biomedicine, polymer science, and infectious disease control. Her technologies have not only influenced the academic community but have also resulted in practical solutions addressing global health crises. Looking ahead, Dr. Yang remains committed to advancing mRNA nanoformulation, antimicrobial therapies, and nanocarrier systems to revolutionize healthcare delivery.

💥 Technical Skills and Expertise

She is a pioneer in the synthesis and characterization of functional polymers, lipid nanoparticles, and self-assembling macromolecules. Her expertise in nanomedicine and drug delivery is complemented by her skills in developing mRNA nanoformulations, antimicrobial polymers, and polymeric hydrogels for various biomedical applications.

👨‍🎓 Teaching Experience and Mentorship

As an Adjunct Professor at NUS, She has actively engaged in mentoring students and early-career researchers, fostering the next generation of scientists. Her leadership roles in research institutes and collaborative projects reflect her dedication to knowledge sharing and academic development.

🛠️ Consultancy and Industry Impact

Her collaborations with industry giants, including IBM, Procter & Gamble, and Merck MSD, have translated scientific innovations into commercial products. These partnerships have led to the development of groundbreaking solutions such as antimicrobial coatings, polymeric hydrogels, and nanocarriers for drug and vaccine delivery, contributing to advancements in healthcare, agriculture, and consumer care.

📖Notable Publications

  1. Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
    • Authors: Bae, K.H., Shunmuganathan, B., Zhang, L., White, K.P., Yang, Y.Y.
    • Journal: npj Vaccines
    • Year: 2024
  2. A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections
    • Authors: Peng, X., Luo, Y., Yang, L., Tian, G.-B., Ding, X.
    • Journal: Journal of Extracellular Vesicles
    • Year: 2024
  3. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer
    • Authors: Li, Y., Li, C., Yan, J., Yang, Y.Y., Yuan, P.
    • Journal: Biomaterials
    • Year: 2024
  4. Quantitative analysis of mRNA-lipid nanoparticle stability in human plasma and serum by size-exclusion chromatography coupled with dual-angle light scattering
    • Authors: Liau, B., Zhang, L., Ang, M.J.Y., Bae, K.H., Yang, Y.Y.
    • Journal: Nanomedicine: Nanotechnology, Biology, and Medicine
    • Year: 2024
  5. Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections
    • Authors: Peng, X., Chen, J., Gan, Y., Yuan, P., Ding, X.
    • Journal: Science Advances
    • Year: 2024